2-FDCK exhibits slower hepatic metabolism than ketamine with an in vitro microsomal half-life of approximately 69 minutes, resulting in longer-lasting subjective effects. Users report a more analytical, less warm dissociation compared to ketamine, with clearer headspace but pronounced motor incoordination. Oral bioavailability appears higher than ketamine, with many users finding oral dosing equally effective to insufflation. The substance produces less nasal irritation than ketamine but saline rinses remain advisable. Reaching a full dissociative state requires higher doses compared to ketamine.
Also known as: 2-Fluorodeshklketamiin, 2-fk, 2f-ket, 2f-ketamiin, Fluoroketamiin, 2-fl-2'-oxo-pcm, 2-(2-fluorophenyl)-2-methylamino-cyclohexanone, 2-Fluoroketamiin
Classification
Chemical: Arylcyclohexylamine
Psychoactive: Dissociative
Tag: Habit-Forming
Tag: Hallucinogen
Tag: Research-Chemical
Tag: Tentative
Effects
Sedation
Pain Relief
Nausea
Numbness
Loss Of Balance
Incoordination
Motor Control Loss
Disconnective Effects
Conceptual Thinking
Cognitive Euphoria
Depersonalization
Derealization
Internal Hallucination
Increased Music Appreciation
Spatial Disorientation
Auditory Distortion
Auditory Suppression
Tactile Suppression
Routes of Administration
Oral / Sublingual
Dosage
Threshold: 5 mg
Light: 5-15 mg
Common: 15-30 mg
Strong: 30-70 mg
Heavy: 70 mg
Duration
Onset: 0.25-1 h
Comeup: 0.75-1.5 h
Peak: 1-2 h
Offset: 1-2 h
After Effects: 1-6 h
Insufflated
Dosage
Threshold: 5 mg
Light: 10 - 45 mg
Common: 45 - 100 mg
Strong: 100 - 175 mg
Heavy: 175 mg
Duration
Onset: 0.02-0.05 h
Comeup: 0.08-0.17 h
Peak: 1-2 h
Offset: 1-2 h
After Effects: 1-4 h
Intramuscular
Dosage
Threshold: 5 mg
Light: 10-20 mg
Common: 20-40 mg
Strong: 40-70 mg
Heavy: 70 mg
Duration
Onset: 0.08-0.17 h
Comeup: 0.17-0.33 h
Peak: 1-2 h
Offset: 1-2 h
After Effects: 1-6 h
Rectal
Dosage
Threshold: 5 mg
Light: 10-25 mg
Common: 25-50 mg
Strong: 50-90 mg
Heavy: 90 mg
Duration
Onset: 0.17-0.5 h
Comeup: 0.5-1 h
Peak: 1-2 h
Offset: 1-2 h
After Effects: 1-6 h
Oral
Dosage
Threshold: 5 mg
Light: 10 - 25 mg
Common: 25 - 70 mg
Strong: 70 - 140 mg
Heavy: 140 mg
Duration
Onset: 0.25-0.83 h
Peak: 0.8-1.7 h
After Effects: 3-8 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
2-FDCK - DrugsPRO ainejuhend
2-FDCK: 2-FDCK exhibits slower hepatic metabolism than ketamine with an in vitro microsomal half-life of approximately 69 minutes, resulting in longer-lasting subjective effects. Users report a more analytical, less warm dissociation compared to ketamine, with clearer headspace but pronounced motor
